Greene John

Greene John is listed in filings as Director at CRISPR Therapeutics AG. This profile follows SEC Form 4 activity through Jun 9, 2026, including purchase activity. Recent filings connect the profile to CRISPR Therapeutics AG (CRSP), Northrop Grumman Corp (NOC), and Discover Financial Services (DFS). The current snapshot covers public activity from Dec 23, 2024 to Jun 9, 2026. Reported amounts are shown as $673.9K to $370.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.